Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing cancer therapeutics that reactivate mutant p53 tumor suppressor protein. Its product candidate, APR-246, is a small molecule p53 reactivator that is in late-stage clinical development for h... Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing cancer therapeutics that reactivate mutant p53 tumor suppressor protein. Its product candidate, APR-246, is a small molecule p53 reactivator that is in late-stage clinical development for hematologic malignancies, including myelodysplastic syndromes (MDS), and acute myeloid leukemia (AML). Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.3272 | -10.0676923077 | 3.25 | 3.54 | 2.865 | 12284 | 3.12328525 | CS |
| 4 | -0.9772 | -25.0564102564 | 3.9 | 4.42 | 2.865 | 14032 | 3.68573275 | CS |
| 12 | -0.6172 | -17.4350282486 | 3.54 | 5.01 | 2.1501 | 23649 | 3.37664737 | CS |
| 26 | -2.3672 | -44.7485822306 | 5.29 | 5.3 | 2.1501 | 16239 | 3.57679995 | CS |
| 52 | -0.8472 | -22.4721485411 | 3.77 | 8.8465 | 2.1501 | 19260 | 5.08603249 | CS |
| 156 | -85.1772 | -96.6824063564 | 88.1 | 94 | 0.474 | 194729 | 31.71057128 | CS |
| 260 | -579.2772 | -99.4979732051 | 582.2 | 1062.2 | 0.474 | 511857 | 116.05112079 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Premium
